{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T05:24:08Z","timestamp":1741238648230,"version":"3.38.0"},"reference-count":0,"publisher":"JLE","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1684\/ejd.2020.3958","type":"journal-article","created":{"date-parts":[[2021,3,29]],"date-time":"2021-03-29T06:43:06Z","timestamp":1617000186000},"page":"99-100","source":"Crossref","is-referenced-by-count":1,"title":["Persistence of superficial basal cell carcinoma during pembrolizumab treatment for metastatic melanoma"],"prefix":"10.1684","volume":"31","author":[{"given":"Irene","family":"Russo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Filoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauro","family":"Alaibac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"18929","container-title":["European Journal of Dermatology"],"original-title":[],"link":[{"URL":"https:\/\/www.jle.com\/10.1684\/ejd.2020.3958","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T16:15:16Z","timestamp":1741191316000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.john-libbey-eurotext.fr\/medline.md?doi=10.1684\/ejd.2020.3958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":0,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,2]]}},"URL":"https:\/\/doi.org\/10.1684\/ejd.2020.3958","relation":{},"ISSN":["1167-1122","1952-4013"],"issn-type":[{"type":"print","value":"1167-1122"},{"type":"electronic","value":"1952-4013"}],"subject":[],"published":{"date-parts":[[2021,2]]}}}